Terms: = Brain cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
814 results:
1. Clinical Management of Patients with Non-Small Cell Lung cancer, brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
3. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
4. An Infant-Type Hemispheric Glioma With SOX5::alk: A Novel Fusion.
Tsai CC; Huang MH; Fang CL; Hsieh KL; Hsieh TH; Ho WL; Chang H; Tsai ML; Kao YC; Miser JS; Wong TT; Su MY; Liu YL
J Natl Compr Canc Netw; 2024 Feb; 22(1):. PubMed ID: 38394779
[TBL] [Abstract] [Full Text] [Related]
5. Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions.
Rosell R; Pedraz-Valdunciel C; Jain A; Shivamallu C; Aguilar A
Expert Opin Investig Drugs; 2024 Mar; 33(3):171-182. PubMed ID: 38372666
[TBL] [Abstract] [Full Text] [Related]
6. Utility of bioelectrical phase angle for cardiovascular risk assessment among individuals with and without diabetes mellitus.
Tsilingiris D; Schimpfle L; Κender Z; Sulaj A; von Rauchhaupt E; Herzig S; Szendroedi J; Kopf S
Diab Vasc Dis Res; 2024; 21(1):14791641231223701. PubMed ID: 38305220
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of Immunohistochemical Expression of alk-1 in Gliomas, WHO Grade 4 and Its Correlation with IDH1-R132H Mutation Status.
Khairy RA; Momtaz EM; Abd El Aziz AM; Shibel PEE
Asian Pac J Cancer Prev; 2024 Jan; 25(1):317-323. PubMed ID: 38285799
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/alk-positive non-small cell lung cancer with brain metastases: a retrospective study.
Qian J; He Z; Wu Y; Li H; Zhang Q; Li X
BMC Cancer; 2024 Jan; 24(1):117. PubMed ID: 38262977
[TBL] [Abstract] [Full Text] [Related]
9. Spine Metastasis Is Associated with the Development of brain Metastasis in Non-Small-Cell Lung cancer Patients.
Cha HK; Ryu WK; Lee HY; Kim HJ; Ryu JS; Lim JH
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256412
[No Abstract] [Full Text] [Related]
10. Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-alk and alk-EML4 in combined treatment of Alectinib and CyberKnife: A case report.
Li Y; Lu S; Yao P; Huang W; Huang Y; Zhou Y; Yuan Y; Cheng S; Wu F
Medicine (Baltimore); 2024 Jan; 103(3):e36992. PubMed ID: 38241569
[TBL] [Abstract] [Full Text] [Related]
11. A case of inflammatory myofibroblastic tumor harboring EML4-alk fusion with a brain metastasis responding to alectinib.
Sakoda S; Tanaka K; Koga Y; Mikumo H; Tsuchiya-Kawano Y; Harada E; Tamiya S; Okamoto I
Thorac Cancer; 2024 Feb; 15(5):415-418. PubMed ID: 38213097
[TBL] [Abstract] [Full Text] [Related]
12. Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (alk)-positive lung cancer and multiple brain metastases.
Murakami Y; Kawashima Y; Chiba S; Hara S; Yamazaki Y; Doman T; Saito S; Odaka T; Ogasawara T; Shimizu H; Sugisaka J; Aiba T; Toi Y; Yamanda S; Kimura Y; Sugawara S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1981. PubMed ID: 38212894
[TBL] [Abstract] [Full Text] [Related]
13. Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer.
Choi YJ; Choi M; Park J; Park M; Kim MJ; Lee JS; Oh SJ; Lee YJ; Shim WS; Kim JW; Kim MJ; Kim YC; Kang KW
Biomed Pharmacother; 2024 Feb; 171():116124. PubMed ID: 38198957
[TBL] [Abstract] [Full Text] [Related]
14. Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia.
Schuermans A; Truong B; Ardissino M; Bhukar R; Slob EAW; Nakao T; Dron JS; Small AM; Cho SMJ; Yu Z; Hornsby W; Antoine T; Lannery K; Postupaka D; Gray KJ; Yan Q; Butterworth AS; Burgess S; Wood MJ; Scott NS; Harrington CM; Sarma AA; Lau ES; Roh JD; Januzzi JL; Natarajan P; Honigberg MC
JAMA Cardiol; 2024 Mar; 9(3):209-220. PubMed ID: 38170504
[TBL] [Abstract] [Full Text] [Related]
15. High efficacy of brigatinib for brain metastases in alk fusion gene-positive non-small cell lung cancer: A case series.
Morikawa K; Numata Y; Shinozaki Y; Kaneko S; Matsushima A; Nishida M; Kida H; Handa H; Nishine H; Mineshita M
Thorac Cancer; 2024 Feb; 15(6):496-499. PubMed ID: 38158887
[TBL] [Abstract] [Full Text] [Related]
16. In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non-small-cell Lung cancer.
Schoenmaekers J; Dijkstra J; van der Wekken A; Paats M; Broen M; Brandts L; Dingemans AM; Hendriks L
Clin Lung Cancer; 2024 Mar; 25(2):168-174.e1. PubMed ID: 38151408
[TBL] [Abstract] [Full Text] [Related]
17. Germline Variants in cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.
Jovanović A; Tošić N; Marjanović I; Komazec J; Zukić B; Nikitović M; Ilić R; Grujičić D; Janić D; Pavlović S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139220
[TBL] [Abstract] [Full Text] [Related]
18. Case report: Successful sequential therapy of crizotinb and entrectinib in ROS1-positive non-small-cell lung cancer with brain metastasis in later-settings.
Dong W; Zhuge J; Yu P; Liu K; Yang M; Wang H
Medicine (Baltimore); 2023 Dec; 102(51):e36591. PubMed ID: 38134118
[TBL] [Abstract] [Full Text] [Related]
19. Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence of
Vargas AC; Joy C; Maclean FM; Bonar F; Wong DD; Gill AJ; Cheah AL
J Clin Pathol; 2024 Mar; 77(4):251-254. PubMed ID: 38053271
[TBL] [Abstract] [Full Text] [Related]
20. Management strategies for intracranial progression in alk-positive non-small cell lung cancer: a real-world cohort study.
Shen CI; Chiang CL; Huang HC; Tseng YH; Luo YH; Yang HC; Chen YM
J Neurooncol; 2023 Dec; 165(3):459-465. PubMed ID: 38051455
[TBL] [Abstract] [Full Text] [Related]
[Next]